The elevated T-maze task as an animal model to simultaneously investigate the effects of drugs on long-term memory and anxiety in mice

Brain Research Bulletin

Volumn 87, Issue 6, 2012, Pages 526-533

  Asth, Laila ^a   Lobão Soares, Bruno ^a   André, Eunice ^a   Soares, Vanessa de Paula ^a   Gavioli, Elaine Cristina ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Animal model; Anxiety; Memory; Mouse

Indexed keywords

BIPERIDEN; DIAZEPAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; ELEVATED T MAZE; LATENT PERIOD; LEARNING DISORDER; LOCOMOTION; MALE; MAZE TEST; MEMORY; MEMORY DISORDER; MOUSE; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BIPERIDEN; DIAZEPAM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; MEMORY, LONG-TERM; MICE; RANDOM ALLOCATION; TIME FACTORS;

EID: 84859162791     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.02.008     Document Type: Article

References (33)

1. Bertoglio L.J., Carobrez A.P. Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2. Behav. Pharmacol. 2004, 15(1):45-54.
2. Bertoglio L.J., Joca S.R., Guimarães F.S. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav. Brain Res. 2006, 175(1):183-188.
3. Bolhuis J.J., Strijkstra A.M., Kramers R.J. Effects of scopolamine on performance of rats in a delayed-response radial maze task. Physiol. Behav. 1988, 43(4):403-409.
4. Brioni J.D., Arolfo M.P. Diazepam impairs retention of spatial information without affecting retrieval or cue learning. Pharmacol. Biochem. Behav. 1992, 41(1):1-5.
5. Buresová O., Bolhuis J.J., Bures J. Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial water maze. Behav. Neurosci. 1986, 100(4):476-482.
6. Carobrez A.P., Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci. Biobehav. Rev. 2005, 29(8):1193-1205.
7. Carvalho-Netto E.F., Nunes-de-Souza R.L. Use of the elevated T-maze to study anxiety in mice?. Behav. Brain Res. 2004, 148(1-2):119-132.
8. Conde C.A., Costa V., Tomaz C. Measuring emotional memory in the elevated T maze using a training-to-criterion procedure. Pharmacol. Biochem. Behav. 1999, 63(1):63-69.
9. Cruz-Morales S.E., García-Saldívar N.L., González-López M.R., Castillo-Roberto G., Monroy J., Domínguez R. Acute restriction impairs memory in the elevated T maze (ETM) and modifies serotonergic activity in the dorsolateral striatum. Behav. Brain Res. 2008, 195(1):187-191.
10. De-Mello N., Carobrez A.P. Elevated T-maze as an animal model of memory: effects of scopolamine. Behav. Pharmacol. 2002, 13(2):139-148.
11. File S.E. The interplay of learning and anxiety in the elevated plus-maze?. Behav. Brain Res. 1993, 58(1-2):199-202.
12. Flood J.F., Cherkin A. Scopolamine effects on memory retention in mice: a model of dementia?. Behav. Neural Biol. 1986, 45(2):169-184.
13. Gazarini L., Stern C.A., Bertoglio L.J. Protein synthesis in dorsal hippocampus supports the drug tolerance induced by prior elevated plus-maze experience. Neuroscience 2011, 179:179-187.
14. Graeff F.G., Viana M.B., Tomaz C. The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam. Braz. J. Med. Biol. Res. 1993, 26(1):67-70.
15. Graeff F.G., Netto C.F., Zangrossi H. The elevated T-maze as an experimental model of anxiety. Neurosci. Biobehav. Rev. 1998, 23(2):237-246.
16. Jensen R.A., Martinez J.L., Vasquez B.J., McGaugh J.L. Benzodiazepines alter acquisition and retention of an inhibitory avoidance response in mice. Psychopharmacology (Berl) 1979, 64(1):125-126.
17. Kimura Y., Ohue M., Kitaura T., Kihira K. Amnesic effects of the anticholinergic drugs, trihexyphenidyl and biperiden: differences in binding properties to the brain muscarinic receptor. Brain Res. 1999, 834(1-2):6-12.
18. Klinkenberg I., Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci. Biobehav. Rev. 2010, 34(8):1307-1350.
19. Klinkenberg I., Blokland A. A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment. Psychopharmacology (Berl) 2011, 215(3):549-566.
20. Lamprea M.R., Cardenas F.P., Silveira R., Morato S., Walsh T.J. Dissociation of memory and anxiety in a repeated elevated plus maze paradigm: forebrain cholinergic mechanisms. Behav. Brain Res. 2000, 117(1-2):97-105.
21. Maia C.do S., Ferreira V.M., Diniz J.S., Carneiro F.P., de Sousa J.B., da Costa E.T., Tomaz C. Inhibitory avoidance acquisition in adult rats exposed to a combination of ethanol and methylmercury during central nervous system development. Behav. Brain Res. 2010, 211(2):191-197.
22. McGaugh J.L. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu. Rev. Neurosci. 2004, 27:1-28.
23. McNamara R.K., Skelton R.W. Diazepam impairs acquisition but not performance in the Morris water maze. Pharmacol. Biochem. Behav. 1991, 38(3):651-658.
24. Pinheiro S.N., Del-Ben C.M., Zangrossi H., Graeff F.G. Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze. J. Psychopharmacol. 2008, 22(2):132-137.
25. Rodgers R.J., Johnson N.J., Cole J.C., Dewar C.V., Kidd G.R., Kimpson P.H. Plus maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade. Pharmacol. Biochem. Behav. 1996, 54(1):41-50.
26. Roldán G., Bolaños-Badillo E., González-Sánchez H., Quirarte G.L., Prado-Alcalá R.A. Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats. Neurosci. Lett. 1997, 230(2):93-96.
27. Rush D.K. Scopolamine amnesia of passive avoidance: a deficit of information acquisition. Behav. Neural Biol. 1988, 50(3):255-274.
28. Santos P., Bittencourt A.S., Schenberg L.C., Carobrez A.P. Elevated T-maze evaluation of anxiety and memory effects of NMDA/glycine-B site ligands injected into the dorsal periaqueductal gray matter and the superior colliculus of rats. Neuropharmacology 2006, 51(2):203-212.
29. Takahashi R.N., Pamplona F.A., Fernandes M.S. The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze. Neurosci. Lett. 2005, 380(3):270-275.
30. Teixeira R.C., Zangrossi H., Graeff F.G. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol. Biochem. Behav. 2000, 65(4):571-576.
31. Tomaz C., Dickinson-Anson H., McGaugh J.L., Souza-Silva M.A., Viana M.B., Graeff F.G. Localization in the amygdala of the amnestic action of diazepam on emotional memory?. Behav. Brain Res. 1993, 58(1-2):99-105.
32. Viana M.B., Tomaz C., Graeff F.G. The elevated T-maze: a new animal model of anxiety and memory. Pharmacol. Biochem. Behav. 1994, 49(3):549-554.
33. Zangrossi H., Graeff F.G. Behavioral validation of the elevated T-maze, a new animal model of anxiety. Brain Res. Bull. 1997, 44(1):1-5.